Feed LFCR
LF

Lifecore Biomedical, Inc.

LFCR · NASDAQ

$4.48 +1.93% (+$0.09)
1M -1.54%
Market Cap $167.3M
P/E Ratio -
Div. Yield -
ROE 376.95%
Piotroski F-Score Moderate
4/9
Valuation
95 /100
Cheap
P/S 1.36x
P/E N/A
EV/EBITDA N/A
Growth
35 /100
Stable
Rev. growth 5.02%
Book val. growth 75.22%
EPS growth N/A
Profitability
11 /100
Weak
Gross margin 29.68%
Net margin 30.40%
Op. margin 2.12%
Quality
7 /100
Poor
ROIC 1.26%
ROE 376.95%
ROA 16.25%
Debt
43 /100
Moderate
Current ratio 3.87x
Int. coverage -0.46x
Debt/Equity N/A
Stability
40 /100
Moderate
Beta 1.09x
Rev. volatility 16.37%
EPS volatility 319.83%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o LFCR
Online

O podjetju

Lifecore Biomedical, Inc. (LFCR) is an American biotechnology company specializing in the development and manufacturing of medical devices and biopharmaceutical products. The company is known for its expertise in hyaluronic acid and its medical applications, offering products for ophthalmic surgery, orthopedics, and aesthetic medicine. Lifecore Biomedical focuses on innovation and continuous improvement of its products to meet the highest standards of quality and efficiency. Lifecore Biomedical, Inc. (LFCR) shares could be suitable for investors looking for investments in the biotechnology and medical devices sector with an emphasis on innovative and specialized products.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Paul Josephs

Employees

382

Headquarters

Chaska

Prihajajoči dogodki

03 NOV.

Earnings

Upcoming earnings report

42d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.